Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement".
LoVecchio
F
F
Curry
S C
SC
Bagnasco
T
T
D015107:4-Butyrolactone / Q000009:adverse effects*; D000328:Adult; D002490:Central Nervous System / Q000187:drug effects*; D003864:Depression, Chemical; D019587:Dietary Supplements / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008297:Male; D012890:Sleep; D012978:Sodium Oxybate / Q000009:adverse effects
D006993:Hypnotics and Sedatives; D012978:Sodium Oxybate; D015107:4-Butyrolactone